Back to search

Medicines Development & Licensing Ltd

05462441

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

3 GARDEN CLOSE, CHIPPING CAMPDEN, GL55 6RT
Incorporated 24/05/2005

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Jennifer Elizabeth Collins

secretary · Since 09/06/2005

DIRECTOR

BRITISH · UNITED KINGDOM · Age 75

Mrs Jennifer Elizabeth Collins

director · Since 09/06/2005

DIRECTOR

BRITISH · ENGLAND · Age 75

Dr Jonathan Douglas Collins

director · Since 09/06/2005

CONSULTANT DRUG DEVELOPMENT & LICENSING

BRITISH · ENGLAND · Age 72

Persons with Significant Control

Dr Jonathan Douglas Collins

ownership-of-shares-25-to-50-percent-as-firm
50–75% votes

British · England · Age 72

3, Garden Close, Chipping Campden, GL55 6RT

Notified 06/04/2016

Mrs Jennifer Elizabeth Collins

25–50% shares
25–50% votes

British · England · Age 75

3, Garden Close, Chipping Campden, GL55 6RT

Notified 24/05/2016

CompanyRankvs 489+ SIC 72110 peers
72

Financial strength49th percentile among SIC peers · 12/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 5.43× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
489Medicines Development & Licensing Ltd
72
How is this score calculated?
Financial strength12/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£150

Balance sheet strength

Cash

£2k

Cash in the bank

Net Current Assets

£147k

Working capital

Current Assets

£180k

Current Liabilities

£33k

Fixed Assets

£7k

Debtors

£437

2avg. employees+1

Balance Sheet

Assets less current liabilities£154k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20255.43
20243.97
202375.72
2022208.29
202125.39
202017.27
201913.81

Derived from filed accounts. Not audited figures.